Kiniksa Pharmaceuticals, Ltd. Intellectual Property Contracts & Agreements

4 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement, dated August 2, 2022, by and among Kiniksa Pharmaceuticals (UK), Ltd., Genentech, Inc. and F. Hoffmann-La Roche Ltd
License Agreements
Kiniksa Pharmaceuticals, Ltd.
Biotechnology
MA
2022
Exclusive License Agreement, dated as of November 1, 2013, by and between The Beth Israel Deaconess Medical Center and Primatope Therapeutics Inc
License Agreements
Kiniksa Pharmaceuticals, Ltd.
Biotechnology
MA
2022
Amendments Nos. 1 and 2 to the License Agreement, dated September 25, 2017, by and between Kiniksa Pharmaceuticals and Regeneron Pharmaceuticals, Inc
License Agreements
Kiniksa Pharmaceuticals, Ltd.
Biotechnology
2021
Amendment No. 1 to the License Agreement, effective as of July 9, 2020, by and between Kiniksa Pharmaceuticals, Ltd. and MedImmune Limited
License Agreements
Kiniksa Pharmaceuticals, Ltd.
Biotechnology
2020